United States · Bill · HR
H.R. 2694 (103rd)
Pharmaceutical Interactions Safety Act
Introduced
21 July 1993
Last action
15 September 1993 · Introduced
Status
Sponsor introductory remarks on measure. (CR E2186-2187)
Sponsors
Rep. Schroeder, Patricia [D-CO-1], Rep. Snowe, Olympia J. [R-ME-2]
Subjects
Healthcare
Source updated
3 June 2026
Summary
Pharmaceutical Interactions Safety Act - Amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to require that drug and biological product investigations include investigations of possible interactions of the drug or biological product with relevant female or male hormones.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 July 1993
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
21 July 1993
Introduced
Introduced in House
Source: IntroReferral
21 July 1993
Introduced
Introduced in House
Source: IntroReferral
3 September 1993
Referred
Referred to the Subcommittee on Health and the Environment.
Source: Committee
15 September 1993
Introduced
Sponsor introductory remarks on measure. (CR E2186-2187)
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 21 July 1993 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 21 July 1993
Introduced in House (PDF)
Introduced in House · EN · 21 July 1993
Introduced in House
summary · EN · 21 July 1993
Sponsors
- Rep. Schroeder, Patricia [D-CO-1] · D · Sponsor
- Rep. Snowe, Olympia J. [R-ME-2] · R · Sponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/2694
- Open data entity: https://api.congress.gov/v3/bill/103/hr/2694
- us · 103-hr-2694 · source updated 3 June 2026